STOCK TITAN

Alphatec Holdings, Inc. - $ATEC STOCK NEWS

Welcome to our dedicated page for Alphatec Holdings news (Ticker: $ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alphatec Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alphatec Holdings's position in the market.

Rhea-AI Summary
Alphatec Holdings, Inc. has successfully closed a $150 million secondary offering, positioning the company to invest in revenue-generating assets and capitalize on industry disruptions. The company expects third quarter 2023 total revenue growth of 31 to 32% and full-year 2023 total revenue of approximately $472 million. Alphatec Holdings will announce its third quarter 2023 financial and operating results on November 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.26%
Tags
none
-
Rhea-AI Summary
Alphatec Holdings, Inc. has closed its underwritten public offering of 14,300,000 shares of common stock at a price of $10.50 per share, resulting in gross proceeds of $150,150,000.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Alphatec Holdings, Inc. announces pricing of public offering of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.22%
Tags
Rhea-AI Summary
Alphatec Holdings, Inc. has announced a proposed underwritten public offering of $150 million of its common stock, with an option for underwriters to purchase an additional $22.5 million of shares. The offering is subject to market conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.22%
Tags
-
Rhea-AI Summary
Alphatec Holdings appoints Dave Demski as independent director and Keith Valentine as Special Advisor to the Board.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none
-
Rhea-AI Summary
Alphatec Holdings enhances EOS platform with automated alignment and surgical planning capabilities
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
Rhea-AI Summary
Alphatec Holdings announces the introduction of the Calibrate LTX lateral expandable implant system at the 2023 NASS Annual Meeting, aimed at improving alignment in lateral surgery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
-
Rhea-AI Summary
Alphatec Holdings, Inc. announces preliminary financial results for Q3 2023 and updates full-year revenue guidance
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.85%
Tags
-
Rhea-AI Summary
Alphatec Holdings, Inc. will showcase innovative spine surgery technology at the NASS Annual Meeting. They will introduce automated alignment and surgical planning capabilities for full release in 2024. ATEC will host a technology-focused meeting for investors on October 18, 2023. Inducement awards have been approved for fifty new employees.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.14%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.63%
Tags
Alphatec Holdings, Inc.

Nasdaq:ATEC

ATEC Rankings

ATEC Stock Data

1.91B
97.84M
34.75%
67.15%
8.96%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
CARLSBAD

About ATEC

as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com